 "GlaxoSmithkline Consumer Q3 net up 21% at Rs 96 crore")
The company had posted a net profit of Rs 79.75 crore in the same period of previous year, GlaxoSmithkline Consumer Healthcare (GSKCH) said in a filing to the BSE.
Net sales of the company rose to Rs 975.17 crore in the quarter under review, up 16.21% compared to Rs 839.11 crore in the corresponding period last year.
Also Read
Commenting on the results, GSKCH Managing Director Zubair Ahmed said: "Despite the category slowdown, we are delighted to show the strongest growth in the FMCG sector in the quarter. This is a clear sign of the consumer acceptance of our products based on high science."
He further said: "Science, innovation, strong distribution and consumer insight based communication remain our growth levers, enabling us to drive growth..."
Overall expenses during the quarter stood at Rs 919.72 crore as against Rs 791.8 crore in the same quarter in the previous fiscal.
Shares of GSKCH closed at Rs 5,640.45 apiece on the BSE, up 0.41% from previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%